$ABBV Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AbbVie Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AbbVie Inc.. Get notifications about new insider transactions in AbbVie Inc. for free.
Page: < prev 1 ... 4 5 6 7 8 9 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 21 2013 | ABBV | AbbVie Inc. | HURWICH THOMAS A. | VP, Controller | Payment of Exercise | F | 48.87 | 1,063 | 51,949 | 51,878 | 52.9 K to 51.9 K (-2.01 %) |
| Nov 21 2013 | ABBV | AbbVie Inc. | HURWICH THOMAS A. | VP, Controller | Buy | M | 24.07 | 2,158 | 51,950 | 52,941 | 50.8 K to 52.9 K (+4.25 %) |
| Oct 02 2013 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Option Exercise | A | 0.00 | 737 | 0 | 2,367 | |
| Oct 02 2013 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 176 | 0 | 564 | |
| Oct 02 2013 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 771 | 0 | 2,474 | |
| Sep 18 2013 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Option Exercise | M | 37.18 | 1,997 | 74,248 | 0 | |
| Sep 18 2013 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Option Exercise | M | 28.86 | 4,600 | 132,769 | 0 | |
| Sep 18 2013 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Option Exercise | M | 28.32 | 2,200 | 62,310 | 0 | |
| Sep 18 2013 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Option Exercise | M | 27.29 | 4,100 | 111,905 | 0 | |
| Sep 18 2013 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Sell | S | 46.48 | 1,789 | 83,153 | 66,703 | 68.5 K to 66.7 K (-2.61 %) |
| Sep 18 2013 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Sell | S | 46.00 | 3,695 | 169,970 | 68,492 | 72.2 K to 68.5 K (-5.12 %) |
| Sep 18 2013 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Buy | M | 37.18 | 1,997 | 74,248 | 72,187 | 70.2 K to 72.2 K (+2.85 %) |
| Sep 18 2013 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Buy | M | 28.86 | 4,600 | 132,769 | 70,190 | 65.6 K to 70.2 K (+7.01 %) |
| Sep 18 2013 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Sell | S | 45.50 | 4,989 | 227,000 | 65,590 | 70.6 K to 65.6 K (-7.07 %) |
| Sep 18 2013 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Buy | M | 28.32 | 2,200 | 62,310 | 70,579 | 68.4 K to 70.6 K (+3.22 %) |
| Sep 18 2013 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Buy | M | 27.29 | 4,100 | 111,905 | 68,379 | 64.3 K to 68.4 K (+6.38 %) |
| Aug 20 2013 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Option Exercise | M | 37.18 | 1,312 | 48,780 | 0 | |
| Aug 20 2013 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Sell | S | 43.01 | 1,270 | 54,623 | 64,279 | 65.5 K to 64.3 K (-1.94 %) |
| Aug 20 2013 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Buy | M | 37.18 | 1,312 | 48,780 | 65,549 | 64.2 K to 65.5 K (+2.04 %) |
| Aug 16 2013 | ABBV | AbbVie Inc. | HURWICH THOMAS A. | VP, Controller | Option Exercise | A | 44.93 | 155 | 6,964 | 155 | |
| Aug 16 2013 | ABBV | AbbVie Inc. | HURWICH THOMAS A. | VP, Controller | Option Exercise | A | 44.93 | 778 | 34,956 | 778 | |
| Aug 16 2013 | ABBV | AbbVie Inc. | HURWICH THOMAS A. | VP, Controller | Option Exercise | A | 44.93 | 3,479 | 156,311 | 3,479 | |
| Aug 16 2013 | ABBV | AbbVie Inc. | HURWICH THOMAS A. | VP, Controller | Option Exercise | A | 44.93 | 562 | 25,251 | 562 | |
| Aug 16 2013 | ABBV | AbbVie Inc. | HURWICH THOMAS A. | VP, Controller | Option Exercise | A | 44.93 | 3,006 | 135,060 | 3,006 | |
| Aug 16 2013 | ABBV | AbbVie Inc. | HURWICH THOMAS A. | VP, Controller | Option Exercise | A | 44.93 | 1,158 | 52,029 | 1,158 | |
| Aug 16 2013 | ABBV | AbbVie Inc. | HURWICH THOMAS A. | VP, Controller | Option Exercise | M | 29.40 | 191 | 5,616 | 0 | |
| Aug 16 2013 | ABBV | AbbVie Inc. | HURWICH THOMAS A. | VP, Controller | Option Exercise | M | 27.63 | 978 | 27,019 | 0 | |
| Aug 16 2013 | ABBV | AbbVie Inc. | HURWICH THOMAS A. | VP, Controller | Option Exercise | M | 27.63 | 4,373 | 120,810 | 0 | |
| Aug 16 2013 | ABBV | AbbVie Inc. | HURWICH THOMAS A. | VP, Controller | Option Exercise | M | 27.93 | 703 | 19,637 | 0 | |
| Aug 16 2013 | ABBV | AbbVie Inc. | HURWICH THOMAS A. | VP, Controller | Option Exercise | M | 27.37 | 3,793 | 103,822 | 0 | |
| Aug 16 2013 | ABBV | AbbVie Inc. | HURWICH THOMAS A. | VP, Controller | Option Exercise | M | 27.15 | 1,465 | 39,780 | 0 | |
| Aug 16 2013 | ABBV | AbbVie Inc. | HURWICH THOMAS A. | VP, Controller | Payment of Exercise | F | 44.93 | 9,138 | 410,570 | 50,783 | 59.9 K to 50.8 K (-15.25 %) |
| Aug 16 2013 | ABBV | AbbVie Inc. | HURWICH THOMAS A. | VP, Controller | Buy | M | 29.40 | 191 | 5,616 | 59,921 | 59.7 K to 59.9 K (+0.32 %) |
| Aug 16 2013 | ABBV | AbbVie Inc. | HURWICH THOMAS A. | VP, Controller | Buy | M | 27.63 | 5,351 | 147,829 | 59,730 | 54.4 K to 59.7 K (+9.84 %) |
| Aug 16 2013 | ABBV | AbbVie Inc. | HURWICH THOMAS A. | VP, Controller | Buy | M | 27.93 | 703 | 19,637 | 54,379 | 53.7 K to 54.4 K (+1.31 %) |
| Aug 16 2013 | ABBV | AbbVie Inc. | HURWICH THOMAS A. | VP, Controller | Buy | M | 27.37 | 3,793 | 103,822 | 53,676 | 49.9 K to 53.7 K (+7.60 %) |
| Aug 16 2013 | ABBV | AbbVie Inc. | HURWICH THOMAS A. | VP, Controller | Buy | M | 27.15 | 1,465 | 39,780 | 49,883 | 48.4 K to 49.9 K (+3.03 %) |
| Aug 20 2013 | ABBV | AbbVie Inc. | Schumacher Laura J | EVP, Bus.Dev.,Ext.A ... | Option Exercise | A | 43.21 | 3,582 | 154,778 | 3,582 | |
| Aug 20 2013 | ABBV | AbbVie Inc. | Schumacher Laura J | EVP, Bus.Dev.,Ext.A ... | Option Exercise | A | 43.21 | 4,473 | 193,278 | 4,473 | |
| Aug 20 2013 | ABBV | AbbVie Inc. | Schumacher Laura J | EVP, Bus.Dev.,Ext.A ... | Option Exercise | A | 43.21 | 873 | 37,722 | 873 | |
| Aug 20 2013 | ABBV | AbbVie Inc. | Schumacher Laura J | EVP, Bus.Dev.,Ext.A ... | Option Exercise | M | 34.49 | 4,011 | 138,335 | 0 | |
| Aug 20 2013 | ABBV | AbbVie Inc. | Schumacher Laura J | EVP, Bus.Dev.,Ext.A ... | Option Exercise | M | 28.91 | 5,425 | 156,863 | 0 | |
| Aug 20 2013 | ABBV | AbbVie Inc. | Schumacher Laura J | EVP, Bus.Dev.,Ext.A ... | Option Exercise | M | 30.21 | 1,039 | 31,392 | 0 | |
| Aug 20 2013 | ABBV | AbbVie Inc. | Schumacher Laura J | EVP, Bus.Dev.,Ext.A ... | Payment of Exercise | F | 43.21 | 8,928 | 385,779 | 247,296 | 256.2 K to 247.3 K (-3.48 %) |
| Aug 20 2013 | ABBV | AbbVie Inc. | Schumacher Laura J | EVP, Bus.Dev.,Ext.A ... | Buy | M | 34.49 | 4,011 | 138,335 | 256,224 | 252.2 K to 256.2 K (+1.59 %) |
| Aug 20 2013 | ABBV | AbbVie Inc. | Schumacher Laura J | EVP, Bus.Dev.,Ext.A ... | Buy | M | 28.91 | 5,425 | 156,863 | 252,213 | 246.8 K to 252.2 K (+2.20 %) |
| Aug 20 2013 | ABBV | AbbVie Inc. | Schumacher Laura J | EVP, Bus.Dev.,Ext.A ... | Buy | M | 30.21 | 1,039 | 31,392 | 246,788 | 245.7 K to 246.8 K (+0.42 %) |
| Aug 13 2013 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Option Exercise | M | 24.07 | 6,842 | 164,708 | 0 | |
| Aug 13 2013 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Option Exercise | A | 45.06 | 1,466 | 66,058 | 1,466 | |
| Aug 13 2013 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Option Exercise | M | 34.76 | 1,734 | 60,281 | 0 | |
| Aug 13 2013 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Option Exercise | M | 24.07 | 2,158 | 51,950 | 0 | |
| Aug 13 2013 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Option Exercise | M | 22.94 | 5,700 | 130,762 | 0 | |
| Aug 13 2013 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Sell | S | 45.01 | 5,006 | 225,307 | 64,237 | 69.2 K to 64.2 K (-7.23 %) |
| Aug 13 2013 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Buy | M | 24.07 | 6,842 | 164,708 | 69,243 | 62.4 K to 69.2 K (+10.96 %) |
| Aug 13 2013 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Payment of Exercise | F | 45.06 | 2,618 | 117,967 | 62,401 | 65 K to 62.4 K (-4.03 %) |
| Aug 13 2013 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Sell | S | 44.78 | 3,845 | 172,176 | 65,019 | 68.9 K to 65 K (-5.58 %) |
| Aug 13 2013 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Buy | M | 34.76 | 1,734 | 60,281 | 68,864 | 67.1 K to 68.9 K (+2.58 %) |
| Aug 13 2013 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Buy | M | 24.07 | 2,158 | 51,950 | 67,130 | 65 K to 67.1 K (+3.32 %) |
| Aug 13 2013 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Buy | M | 22.94 | 5,700 | 130,762 | 64,972 | 59.3 K to 65 K (+9.62 %) |
| Aug 02 2013 | ABBV | AbbVie Inc. | Schumacher Laura J | EVP, Bus.Dev.,Ext.A ... | Option Exercise | M | 32.57 | 5,634 | 183,511 | 0 | |
| Aug 02 2013 | ABBV | AbbVie Inc. | Schumacher Laura J | EVP, Bus.Dev.,Ext.A ... | Option Exercise | M | 32.57 | 774 | 25,211 | 0 | |
| Aug 02 2013 | ABBV | AbbVie Inc. | Schumacher Laura J | EVP, Bus.Dev.,Ext.A ... | Payment of Exercise | F | 45.48 | 5,443 | 247,548 | 245,749 | 251.2 K to 245.7 K (-2.17 %) |
| Aug 02 2013 | ABBV | AbbVie Inc. | Schumacher Laura J | EVP, Bus.Dev.,Ext.A ... | Buy | M | 32.57 | 5,634 | 183,511 | 251,192 | 245.6 K to 251.2 K (+2.29 %) |
| Aug 02 2013 | ABBV | AbbVie Inc. | Schumacher Laura J | EVP, Bus.Dev.,Ext.A ... | Buy | M | 32.57 | 774 | 25,211 | 245,558 | 244.8 K to 245.6 K (+0.32 %) |
| Jul 01 2013 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 190 | 0 | 385 | |
| Jul 01 2013 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Option Exercise | A | 0.00 | 798 | 0 | 1,614 | |
| Jul 01 2013 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 834 | 0 | 1,687 | |
| May 08 2013 | ABBV | AbbVie Inc. | WADDELL FREDERICK H | Director | Grant | A | 0.00 | 2,535 | 0 | 4,535 | 2 K to 4.5 K (+126.75 %) |
| May 08 2013 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Grant | A | 0.00 | 2,535 | 0 | 21,741 | 19.2 K to 21.7 K (+13.20 %) |
| May 08 2013 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Grant | A | 0.00 | 2,535 | 0 | 5,035 | 2.5 K to 5 K (+101.40 %) |
| May 08 2013 | ABBV | AbbVie Inc. | ROBERTS ROY S | Director | Grant | A | 0.00 | 2,535 | 0 | 22,535 | 20 K to 22.5 K (+12.68 %) |
| May 08 2013 | ABBV | AbbVie Inc. | LIDDY EDWARD M | Director | Grant | A | 0.00 | 2,535 | 0 | 7,656 | 5.1 K to 7.7 K (+49.50 %) |
| May 08 2013 | ABBV | AbbVie Inc. | BURNSIDE WILLIAM H.L. | Director | Grant | A | 0.00 | 2,535 | 0 | 2,535 | 0 to 2.5 K |
| May 08 2013 | ABBV | AbbVie Inc. | AUSTIN ROXANNE S | Director | Grant | A | 0.00 | 2,535 | 0 | 25,601 | 23.1 K to 25.6 K (+10.99 %) |
| May 08 2013 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Grant | A | 0.00 | 2,535 | 0 | 11,094 | 8.6 K to 11.1 K (+29.62 %) |
| May 03 2013 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Option Exercise | M | 28.31 | 34,600 | 979,602 | 0 | |
| May 03 2013 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Option Exercise | M | 26.85 | 21,000 | 563,791 | 0 | |
| May 03 2013 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Option Exercise | M | 28.13 | 17,700 | 497,814 | 0 | |
| May 03 2013 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Option Exercise | M | 28.86 | 33,900 | 978,449 | 0 | |
| May 03 2013 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Option Exercise | M | 27.29 | 35,700 | 974,396 | 0 | |
| May 03 2013 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Sell | S | 45.68 | 27,664 | 1,263,683 | 176,079 | 203.7 K to 176.1 K (-13.58 %) |
| May 03 2013 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Sell | S | 45.68 | 30,550 | 1,395,426 | 203,743 | 234.3 K to 203.7 K (-13.04 %) |
| May 03 2013 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Sell | S | 45.66 | 27,320 | 1,247,562 | 234,293 | 261.6 K to 234.3 K (-10.44 %) |
| May 03 2013 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Sell | S | 45.68 | 28,122 | 1,284,717 | 261,613 | 289.7 K to 261.6 K (-9.71 %) |
| May 03 2013 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Buy | M | 28.31 | 34,600 | 979,602 | 289,735 | 255.1 K to 289.7 K (+13.56 %) |
| May 03 2013 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Buy | M | 26.85 | 21,000 | 563,791 | 255,135 | 234.1 K to 255.1 K (+8.97 %) |
| May 03 2013 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Buy | M | 28.13 | 17,700 | 497,814 | 234,135 | 216.4 K to 234.1 K (+8.18 %) |
| May 03 2013 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Buy | M | 28.86 | 33,900 | 978,449 | 216,435 | 182.5 K to 216.4 K (+18.57 %) |
| May 03 2013 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Buy | M | 27.29 | 35,700 | 974,396 | 182,535 | 146.8 K to 182.5 K (+24.31 %) |
| Apr 05 2013 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Gift | G | 0.00 | 10 | 0 | 284,053 | 284.1 K to 284.1 K (0.00 %) |
| Apr 02 2013 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Gift | G | 0.00 | 12,243 | 0 | 284,063 | 296.3 K to 284.1 K (-4.13 %) |
| Apr 02 2013 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 193 | 0 | 193 | |
| Apr 02 2013 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Option Exercise | A | 0.00 | 809 | 0 | 809 | |
| Apr 02 2013 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 846 | 0 | 846 | |
| Mar 19 2013 | ABBV | AbbVie Inc. | LEONARD JOHN M. | SVP, Chief Scientif ... | Option Exercise | M | 28.86 | 46,700 | 1,347,893 | 46,700 | |
| Mar 19 2013 | ABBV | AbbVie Inc. | LEONARD JOHN M. | SVP, Chief Scientif ... | Sell | S | 38.45 | 46,700 | 1,795,615 | 107,320 | 154 K to 107.3 K (-30.32 %) |
| Mar 19 2013 | ABBV | AbbVie Inc. | LEONARD JOHN M. | SVP, Chief Scientif ... | Buy | M | 28.86 | 46,700 | 1,347,893 | 154,020 | 107.3 K to 154 K (+43.51 %) |
| Mar 12 2013 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Buy | P | 37.67 | 600 | 22,600 | 2,500 | 1.9 K to 2.5 K (+31.58 %) |
| Mar 12 2013 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Buy | P | 37.66 | 100 | 3,766 | 1,900 | 1.8 K to 1.9 K (+5.56 %) |
| Mar 12 2013 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Buy | P | 37.67 | 100 | 3,767 | 1,800 | 1.7 K to 1.8 K (+5.88 %) |
| Mar 12 2013 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Buy | P | 37.66 | 100 | 3,766 | 1,700 | 1.6 K to 1.7 K (+6.25 %) |
| Mar 12 2013 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Buy | P | 37.66 | 100 | 3,766 | 1,600 | 1.5 K to 1.6 K (+6.67 %) |
| Mar 12 2013 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Buy | P | 37.66 | 100 | 3,766 | 1,500 | 1.4 K to 1.5 K (+7.14 %) |
| Mar 12 2013 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Buy | P | 37.66 | 200 | 7,533 | 1,400 | 1.2 K to 1.4 K (+16.67 %) |
| Mar 12 2013 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Buy | P | 37.67 | 1,200 | 45,204 | 1,200 | 0 to 1.2 K |
| Mar 12 2013 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Sell | S | 37.50 | 496 | 18,600 | 59,272 | 59.8 K to 59.3 K (-0.83 %) |
| Mar 12 2013 | ABBV | AbbVie Inc. | LEONARD JOHN M. | SVP, Chief Scientif ... | Sell | S | 37.50 | 23,644 | 886,650 | 107,320 | 131 K to 107.3 K (-18.05 %) |
| Mar 12 2013 | ABBV | AbbVie Inc. | LEONARD JOHN M. | SVP, Chief Scientif ... | Sell | S | 37.58 | 4,305 | 161,782 | 130,964 | 135.3 K to 131 K (-3.18 %) |
| Mar 04 2013 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Payment of Exercise | F | 36.73 | 7,716 | 283,409 | 296,306 | 304 K to 296.3 K (-2.54 %) |
| Mar 04 2013 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Payment of Exercise | F | 36.73 | 12,960 | 476,021 | 146,835 | 159.8 K to 146.8 K (-8.11 %) |
| Mar 04 2013 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Payment of Exercise | F | 36.73 | 5,260 | 193,200 | 138,656 | 143.9 K to 138.7 K (-3.65 %) |
| Mar 04 2013 | ABBV | AbbVie Inc. | HURWICH THOMAS A. | VP, Controller | Payment of Exercise | F | 36.73 | 2,191 | 80,475 | 48,418 | 50.6 K to 48.4 K (-4.33 %) |
| Mar 04 2013 | ABBV | AbbVie Inc. | Schumacher Laura J | EVP, Bus.Dev.,Ext.A ... | Payment of Exercise | F | 36.73 | 19,517 | 716,859 | 244,784 | 264.3 K to 244.8 K (-7.38 %) |
| Mar 04 2013 | ABBV | AbbVie Inc. | LEONARD JOHN M. | SVP, Chief Scientif ... | Payment of Exercise | F | 36.73 | 9,407 | 345,519 | 135,269 | 144.7 K to 135.3 K (-6.50 %) |
| Mar 04 2013 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Payment of Exercise | F | 36.73 | 1,479 | 54,324 | 59,768 | 61.2 K to 59.8 K (-2.41 %) |
| Feb 21 2013 | ABBV | AbbVie Inc. | LEONARD JOHN M. | SVP, Chief Scientif ... | Option Exercise | M | 27.29 | 29,650 | 809,267 | 29,650 | |
| Feb 21 2013 | ABBV | AbbVie Inc. | LEONARD JOHN M. | SVP, Chief Scientif ... | Payment of Exercise | F | 37.58 | 25,345 | 952,465 | 148,981 | 174.3 K to 149 K (-14.54 %) |
| Feb 21 2013 | ABBV | AbbVie Inc. | LEONARD JOHN M. | SVP, Chief Scientif ... | Buy | M | 27.29 | 29,650 | 809,267 | 174,326 | 144.7 K to 174.3 K (+20.49 %) |
| Feb 19 2013 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Option Exercise | A | 35.88 | 115,830 | 4,155,980 | 115,830 | |
| Feb 19 2013 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Payment of Exercise | F | 37.58 | 9,826 | 369,261 | 159,795 | 169.6 K to 159.8 K (-5.79 %) |
| Feb 19 2013 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Grant | A | 0.00 | 56,700 | 0 | 169,621 | 112.9 K to 169.6 K (+50.21 %) |
| Feb 19 2013 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Option Exercise | A | 35.88 | 526,430 | 18,888,308 | 526,430 | |
| Feb 19 2013 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Payment of Exercise | F | 37.58 | 3,130 | 117,625 | 304,022 | 307.2 K to 304 K (-1.02 %) |
| Feb 19 2013 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Grant | A | 0.00 | 257,720 | 0 | 307,152 | 49.4 K to 307.2 K (+521.36 %) |
| Feb 19 2013 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Option Exercise | A | 35.88 | 115,830 | 4,155,980 | 115,830 | |
| Feb 19 2013 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Payment of Exercise | F | 37.58 | 2,912 | 109,433 | 143,916 | 146.8 K to 143.9 K (-1.98 %) |
| Feb 19 2013 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Grant | A | 0.00 | 56,700 | 0 | 146,828 | 90.1 K to 146.8 K (+62.91 %) |
| Feb 19 2013 | ABBV | AbbVie Inc. | Schumacher Laura J | EVP, Bus.Dev.,Ext.A ... | Option Exercise | A | 35.88 | 145,510 | 5,220,899 | 145,510 | |
| Feb 19 2013 | ABBV | AbbVie Inc. | Schumacher Laura J | EVP, Bus.Dev.,Ext.A ... | Payment of Exercise | F | 37.58 | 15,024 | 564,602 | 264,301 | 279.3 K to 264.3 K (-5.38 %) |
| Feb 19 2013 | ABBV | AbbVie Inc. | Schumacher Laura J | EVP, Bus.Dev.,Ext.A ... | Grant | A | 0.00 | 71,230 | 0 | 279,325 | 208.1 K to 279.3 K (+34.23 %) |
| Feb 19 2013 | ABBV | AbbVie Inc. | Schumacher Laura J | EVP, Bus.Dev.,Ext.A ... | Option Exercise | A | 35.88 | 145,510 | 5,220,899 | 145,510 | |
| Feb 19 2013 | ABBV | AbbVie Inc. | Schumacher Laura J | EVP, Bus.Dev.,Ext.A ... | Payment of Exercise | F | 37.58 | 15,024 | 564,602 | 264,301 | 279.3 K to 264.3 K (-5.38 %) |
| Feb 19 2013 | ABBV | AbbVie Inc. | Schumacher Laura J | EVP, Bus.Dev.,Ext.A ... | Grant | A | 0.00 | 71,230 | 0 | 279,325 | 208.1 K to 279.3 K (+34.23 %) |
| Feb 19 2013 | ABBV | AbbVie Inc. | HURWICH THOMAS A. | VP, Controller | Option Exercise | A | 35.88 | 35,620 | 1,278,046 | 35,620 | |
| Feb 19 2013 | ABBV | AbbVie Inc. | HURWICH THOMAS A. | VP, Controller | Payment of Exercise | F | 37.58 | 2,265 | 85,119 | 50,609 | 52.9 K to 50.6 K (-4.28 %) |
| Feb 19 2013 | ABBV | AbbVie Inc. | HURWICH THOMAS A. | VP, Controller | Grant | A | 0.00 | 17,440 | 0 | 52,874 | 35.4 K to 52.9 K (+49.22 %) |
| Feb 08 2013 | ABBV | AbbVie Inc. | Schumacher Laura J | Option Exercise | M | 32.57 | 165 | 5,374 | 0 | ||
| Feb 08 2013 | ABBV | AbbVie Inc. | Schumacher Laura J | Option Exercise | M | 32.47 | 3,611 | 117,242 | 0 | ||
| Feb 08 2013 | ABBV | AbbVie Inc. | Schumacher Laura J | Payment of Exercise | F | 37.14 | 3,466 | 128,727 | 208,095 | 211.6 K to 208.1 K (-1.64 %) | |
| Feb 08 2013 | ABBV | AbbVie Inc. | Schumacher Laura J | Buy | M | 32.57 | 165 | 5,374 | 211,561 | 211.4 K to 211.6 K (+0.08 %) | |
| Feb 08 2013 | ABBV | AbbVie Inc. | Schumacher Laura J | Buy | M | 32.47 | 3,611 | 117,242 | 211,396 | 207.8 K to 211.4 K (+1.74 %) | |
| Feb 19 2013 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | SVP, Human Resource ... | Option Exercise | A | 35.88 | 87,040 | 3,122,995 | 87,040 | |
| Feb 19 2013 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | SVP, Human Resource ... | Payment of Exercise | F | 37.58 | 464 | 17,437 | 90,165 | 90.6 K to 90.2 K (-0.51 %) |
| Feb 19 2013 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | SVP, Human Resource ... | Payment of Exercise | F | 37.58 | 496 | 18,640 | 90,629 | 91.1 K to 90.6 K (-0.54 %) |
| Feb 19 2013 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | SVP, Human Resource ... | Payment of Exercise | F | 37.58 | 534 | 20,068 | 91,125 | 91.7 K to 91.1 K (-0.58 %) |
| Feb 19 2013 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | SVP, Human Resource ... | Grant | A | 0.00 | 42,610 | 0 | 91,659 | 49 K to 91.7 K (+86.87 %) |
| Feb 19 2013 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Option Exercise | A | 35.88 | 74,520 | 2,673,778 | 74,520 | |
| Feb 19 2013 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Payment of Exercise | F | 37.58 | 421 | 15,821 | 61,247 | 61.7 K to 61.2 K (-0.68 %) |
| Feb 19 2013 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Grant | A | 0.00 | 36,480 | 0 | 61,668 | 25.2 K to 61.7 K (+144.83 %) |
| Feb 19 2013 | ABBV | AbbVie Inc. | LEONARD JOHN M. | SVP, Chief Scientif ... | Option Exercise | A | 35.88 | 62,020 | 2,225,278 | 62,020 |